Preliminary Validation of the Cancer Worry Scale in Pediatric Survivors of Childhood Cancer
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.31967 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von K Brooke Russell und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Cancer Survivors, Psychometrics, Anxiety, Neoplasms. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background
Relatively little is known about the fear of cancer recurrence (FCR) experienced by youth. Contributing to this challenge is the scarcity of validated tools available to measure FCR experienced by children and adolescents under age 18. Our aim was to evaluate the psychometric properties of the Cancer Worry Scale (CWS) in a pediatric sample. Procedure Participants ( n = 70), 8–17 years of age, completed the CWS. We evaluated psychometric properties of both the CWS‐6 and CWS‐8 and conducted exploratory factor analyses (EFAs) for each to evaluate the number of factors, variance explained, and item fit. Correlations between the CWS and IUSC‐12, PROMIS Anxiety‐8a, PROMIS Depression‐8a, and PedsQL were assessed for evidence of convergent and divergent validity.
Results
Individual CWS items had acceptable psychometric characteristics, except for Item 3, which performed poorly across analyses. Both CWS versions demonstrated floor effects, with no participants endorsing the highest scores. Internal consistency reliability was good for both the CWS‐6 ( α = 0.91) and CWS‐8 ( α = 0.92). EFA produced a single factor solution for both CWS versions, accounting for 62%–65% of total variance. Both CWS versions were predictably correlated with measures indicating convergent (Intolerance of Uncertainty Scale for Children‐12, PROMIS Anxiety‐8a, PROMIS Depression‐8a; r = 0.464–0.535, p < 0.001) and divergent validity (PedsQL; r = −0.285 to −0.324, p < 0.05).
Conclusions
Preliminary results are consistent with the extant literature and suggest the CWS may be used effectively with pediatric samples. Continued exploration of FCR experienced by pediatric survivors is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
- Hematology, Oncology, and Transplant Program, Alberta Children's Hospital, Calgary, Alberta, Canada.
- Seattle Children's Hospital, Seattle, Washington, USA.
- Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
- Division of Psychosocial Oncology, Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
- Werklund School of Education, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: K Brooke Russell, Fiona Schulte
Zitieren
APA
Russell, K. B., Patton, M., Verhesen, T., Forbes, C., Stokoe, M., Guilcher, G., Tomfohr-Madsen, L., & Schulte, F. (2025). Preliminary Validation of the Cancer Worry Scale in Pediatric Survivors of Childhood Cancer. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31967
Vancouver
Russell KB, Patton M, Verhesen T, Forbes C, Stokoe M, Guilcher G, et al. Preliminary Validation of the Cancer Worry Scale in Pediatric Survivors of Childhood Cancer. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31967
BibTeX
@article{Russell2025,
author = {Russell, K Brooke and Patton, Michaela and Verhesen, Tessa and Forbes, Caitlin and Stokoe, Mehak and Guilcher, Gregory and Tomfohr-Madsen, Lianne and Schulte, Fiona},
title = {Preliminary Validation of the Cancer Worry Scale in Pediatric Survivors of Childhood Cancer},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.31967}
}
EUVIMED